126 related articles for article (PubMed ID: 10813278)
21. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk factors in women with and without rheumatoid arthritis.
Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
[TBL] [Abstract][Full Text] [Related]
23. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
25. Increased ferritin response in adult Still's disease: specificity and relationship to outcome.
Evensen KJ; Swaak TJ; Nossent JC
Scand J Rheumatol; 2007; 36(2):107-10. PubMed ID: 17476616
[TBL] [Abstract][Full Text] [Related]
26. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
27. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.
Brown DA; Moore J; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN
Arthritis Rheum; 2007 Mar; 56(3):753-64. PubMed ID: 17328047
[TBL] [Abstract][Full Text] [Related]
28. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
29. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
Wolbink GJ; Voskuyl AE; Lems WF; de Groot E; Nurmohamed MT; Tak PP; Dijkmans BA; Aarden L
Ann Rheum Dis; 2005 May; 64(5):704-7. PubMed ID: 15485995
[TBL] [Abstract][Full Text] [Related]
30. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
31. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
32. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
[TBL] [Abstract][Full Text] [Related]
33. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
34. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.
Sverdrup B; Källberg H; Bengtsson C; Lundberg I; Padyukov L; Alfredsson L; Klareskog L;
Arthritis Res Ther; 2005; 7(6):R1296-303. PubMed ID: 16277683
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
Buch MH; Seto Y; Bingham SJ; Bejarano V; Bryer D; White J; Emery P
Arthritis Rheum; 2005 Jan; 52(1):42-8. PubMed ID: 15641046
[TBL] [Abstract][Full Text] [Related]
36. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
37. Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study.
Pedersen M; Jacobsen S; Klarlund M; Frisch M
J Rheumatol; 2006 Jun; 33(6):1069-74. PubMed ID: 16622905
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
Cisternas M; Gutiérrez MA; Klaassen J; Acosta AM; Jacobelli S
J Rheumatol; 2002 Aug; 29(8):1619-22. PubMed ID: 12180719
[TBL] [Abstract][Full Text] [Related]
39. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
40. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
